Transforming Medicines Manufacturing
Innovate UK’s Medicines Manufacturing programmes aim to drive the de-risking and adoption of highly innovative flexible, agile and scalable manufacturing technologies through a culture of collaboration that will drive the growth of this critically important manufacturing sector.
About the programme
The Transforming Medicines Manufacturing (TMM) programme leads on from the ISCF Medicines Manufacturing Challenge Community, which was established in 2017 and ran until 2022, and has been designed to support and grow the UK’s capabilities in manufacturing medicines by developing first-of-a-kind technologies to accelerate patient access to new drugs and treatments.
TMM consists of a range of funding competitions as well as a Community of Practice which will include a range of face-to-face events, interactive workshops and webinars amongst other activities.
Programme objectives
- De-risk the use of technologies in innovative manufacturing.
- Drive disruptive technology innovation of long-term strategic importance.
- Build resilience and growth in the medicines manufacturing sector ensuring health security and patient benefit.
- Support economic recovery and levelling up through supporting job creation, skills development and encouraging inward investment.
- Supporting ambitious ED&I goals across the sector to establish a culture of change.
- Address the Net Zero agenda and sustainability goals through funding novel manufacturing technologies to improve yields reduce waste and cut emissions.
Transforming Medicines Manufacturing introduction
The key to the UK’s future as a global medicines manufacturing hub is its people. The Medicines Manufacturing Challenge has laid the groundwork for building this highly skilled workforce, but we need to continue to nurture the pipeline for the next generation of scientists, engineers and technicians to maintain a thriving industry.
Focus Areas
FOCUS AREA
Nucleic Acid Medicines Manufacturing
Improving the resource efficiency, productivity, and scalability for the manufacture of nucleic acid medicines.
FOCUS AREA
Digitalisation and automation
Driving digitalisation and automation technologies in the development and manufacture of medicines.
FOCUS AREA
Intracellular drug delivery
Development and manufacturing of innovative formulations for DNA and RNA-based medicines.
FOCUS AREA
Flexible, Agile, Sustainable, Scalable Technologies
Investing in advanced manufacturing technologies for better, more responsive manufacturing approaches.
FOCUS AREA
Simplified Delivery of Complex Medicines
Accelerating innovation in complex medicines formulation, manufacturing, and delivery.
The Community of Practice
A collaborative forum, bringing together key stakeholders to drive forward cutting-edge innovation in medicines manufacturing in the UK.
Read more
Our Experts
Related Opportunities
Flexible, agile, scalable and sustainable medicines manufacturing
Opens: 26/09/2023 Closes: 22/11/2023
UK registered organisations can apply for a share of up to £5m for development and implementation of technologies for medicines development and manufacture.
More Information
Canada-UK: Biomanufacturing of Biologics and Advanced Therapies
Opens: 26/06/2023 Closes: 17/10/2023
UK registered organisations can apply for a share of up to £3.5m to collaborate with Canadian SMEs on joint R&D to innovate in biomanufacturing biologics and advanced therapies.
More Information
Innovate UK innovation loans future economy: round 11
Opens: 14/09/2023 Closes: 08/11/2023
UK registered businesses can apply for loans for innovative projects with strong commercial potential to significantly improve the UK economy.
More Information
Related News
11/07/2023
Help us shape the future of innovation!
Innovate UK is looking to expand their assessor pool to review applications in the Health and Life Sciences area. Join us and be part of a vibrant community of experts dedicated to driving innovation forward.
Read more
02/05/2023
Pilot accelerators launched to support the development of early-stage health and life science innovation in the UK
We are pleased to announce our pilot accelerators, in collaboration with the Medical Research Council (MRC), which will allow spinouts, start-ups, and entrepreneurial minded academics to test their ideas and develop concepts with support from key stakeholders from the innovation ecosystem.
Read more
Join the community
Join the medicines manufacturing community of practice to stay up to date with the latest news, grant funding, policy changes and regulatory announcements. Interact and collaborate with other organisations and help shape the future of medicines manufacturing in the UK.